In 2015, the Neulasta On-Body Injector (OBI) Onpro device was introduced as a less costly method of pegfilgrastim administration. While the device has been found to be safe in healthy volunteers and ...

With 6 pegfilgrastim biosimilars approved, and multiple administration options, a patient-centric model of pegfilgrastim administration should be possible for patients with cancer who require ...

PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC (“Kashiv” or the “Company”) today announced that Health Canada has granted marketing authorization for its Pegfilgrastim Injection, enabling ...

Neulasta (pegfilgrastim) is a brand-name drug that’s prescribed to treat radiation sickness and prevent certain complications of chemotherapy. Neulasta comes as an injectable solution. The dosage can ...

Neulasta Delivery Kit Provides Administration Option for Patients who may not Otherwise Need to Return to Clinic or Hospital the day After Chemotherapy One of the most common side effects of ...

BLOOMFIELD, Conn., June 13, 2023 /PRNewswire/ -- A new study by Cigna Healthcare found that site-of-care redirection is associated with favorable clinical outcomes and increased access and ...

The Food and Drug Administration approves Nyvepria, the biosimilar to Neulasta, to help treat and prevent infections in patients undergoing myelosuppressive chemotherapy. The Food and Drug ...

A Cigna Healthcare study found administering pegfilgrastim, an injection used to prevent infection in cancer patients, in a home setting increased patient outcomes compared to administration in a ...

In its second untitled letter of 2021, the US Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP) flagged issues with Amgen’s promotion of its biological product Neulasta ...

LANSING, Mich. — A new report released by the Michigan Health Purchasers Coalition (MIHPC) is showing massive drug price disparities between hospitals in the state. The report highlighted three ...

Neulasta Delivery Kit Provides Administration Option for Patients who may not Otherwise Need to Return to Clinic or Hospital the day After Chemotherapy THOUSAND OAKS, Calif., March 2, 2015 /PRNewswire ...